Biocon founder Kiran Mazumdar-Shaw reflects on building her biotechnology venture from a garage shed in India in 1978.
Assertion Contradicted
Mazumdar-Shaw: Vijay Mallya has paid back everything he owed
“Well, he's paid back everything he owed. So I don't understand why he's still being targeted.”
Prediction Not checkable as stated
Mazumdar-Shaw: Entering biosimilars now would severely hurt Indian pharma earnings
“If any Indian pharmaceutical company wants to now venture into biosimilars, like I have done, it will, you know, have a huge impact on their EBITDA and their earnings, which I don't think anyone wants to do at this point in time.”
Prediction Not checkable as stated
Mazumdar-Shaw: Regulations will permit CRISPR for genetic defects, not designer babies
“So I think they will allow you to use CRISPR technologies like they use gene therapies today. To basically correct genetic deficiencies, but not to choose the kind of baby you want, you know, like saying that, okay, I want my eyes, the eyes to be of this color…”
Insight
Mazumdar-Shaw: Going public creates valuation currency essential for scaling
“I believe that as you grow your company, you need you need a capital value for a kind of a currency that you use to grow your company with. So if you create a valuation for your company, you can use that as a very, very powerful currency to do many more things…”
Insight
Mazumdar-Shaw: People without children tend to be more philanthropic
“When you don't have kids, you tend to Be more philanthropic.”
Opinion
Mazumdar-Shaw: The Modi government's stable economic policies appeal globally
“Now, obviously, the Modi government has done extremely well. It's been around for a long time, and they've basically made sure that economic policies are very stable, and that really appeals to the outside world, whether it's investors, whether it's other gove…”